Works matching AU Bakris, George


Results: 499
    1
    2
    3

    Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.

    Published in:
    2019
    By:
    • Bakris, George L.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Nowack, Christina;
    • Kolkhof, Peter;
    • Ferreira, Anna C.;
    • Schloemer, Patrick;
    • Filippatos, Gerasimos;
    • Bakris, George L;
    • Anker, Stefan D;
    • Ruilope, Luis M;
    • Ferreira, Anna C;
    • on behalf of the FIDELIO-DKD study investigators;
    • FIDELIO-DKD study investigators
    Publication type:
    journal article
    4
    5
    6
    7
    8

    A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.

    Published in:
    Clinical Kidney Journal, 2023, v. 16, n. 2, p. 293, doi. 10.1093/ckj/sfac234
    By:
    • Agarwal, Rajiv;
    • Pitt, Bertram;
    • Palmer, Biff F;
    • Kovesdy, Csaba P;
    • Burgess, Ellen;
    • Filippatos, Gerasimos;
    • Małyszko, Jolanta;
    • Ruilope, Luis M;
    • Rossignol, Patrick;
    • Rossing, Peter;
    • Pecoits-Filho, Roberto;
    • Anker, Stefan D;
    • Joseph, Amer;
    • Lawatscheck, Robert;
    • Wilson, Daniel;
    • Gebel, Martin;
    • Bakris, George L
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685
    By:
    • Cardoza, Kathryn;
    • Kang, Amy;
    • Smyth, Brendan;
    • Yi, Tae Won;
    • Pollock, Carol;
    • Agarwal, Rajiv;
    • Bakris, George;
    • Charytan, David M.;
    • de Zeeuw, Dick;
    • Wheeler, David C.;
    • Zhang, Hong;
    • Cannon, Christopher P.;
    • Perkovic, Vlado;
    • Arnott, Clare;
    • Levin, Adeera;
    • Mahaffey, Kenneth W.
    Publication type:
    Article
    15
    16

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    17

    Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    18

    Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232
    By:
    • Heerspink, Hiddo J. L.;
    • Vart, Priya;
    • Jongs, Niels;
    • Neuen, Brendon L.;
    • Bakris, George;
    • Claggett, Brian;
    • Vaduganathan, Muthiah;
    • McCausland, Finnian;
    • Docherty, Kieran F.;
    • Jhund, Pardeep S.;
    • Solomon, Scott D.;
    • Perkovic, Vlado;
    • McMurray, John J. V.
    Publication type:
    Article
    19

    Back Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    20

    The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    21

    The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091
    By:
    • Kang, Amy;
    • Smyth, Brendan;
    • Neuen, Brendon L.;
    • Heerspink, Hiddo J. L.;
    • Di Tanna, Gian Luca;
    • Zhang, Hong;
    • Arnott, Clare;
    • Hockham, Carinna;
    • Agarwal, Rajiv;
    • Bakris, George;
    • Charytan, David M.;
    • de Zeeuw, Dick;
    • Greene, Tom;
    • Levin, Adeera;
    • Pollock, Carol;
    • Wheeler, David C.;
    • Mahaffey, Kenneth W.;
    • Perkovic, Vlado;
    • Jardine, Meg J.
    Publication type:
    Article
    22

    Cover Image.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    23

    Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    24
    25

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. C1, doi. 10.1111/dom.14995
    By:
    • Rossing, Peter;
    • Garweg, Justus G.;
    • Anker, Stefan D.;
    • Osonoi, Takeshi;
    • Pitt, Bertram;
    • Rosas, Sylvia E.;
    • Ruilope, Luis Miguel;
    • Zhu, Dalong;
    • Brinker, Meike;
    • Finis, David;
    • Leal, Sergio;
    • Schmelter, Thomas;
    • Bakris, George
    Publication type:
    Article
    26

    Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 894, doi. 10.1111/dom.14915
    By:
    • Rossing, Peter;
    • Garweg, Justus G.;
    • Anker, Stefan D.;
    • Osonoi, Takeshi;
    • Pitt, Bertram;
    • Rosas, Sylvia E.;
    • Ruilope, Luis Miguel;
    • Zhu, Dalong;
    • Brinker, Meike;
    • Finis, David;
    • Leal, Sergio;
    • Schmelter, Thomas;
    • Bakris, George
    Publication type:
    Article
    27

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
    By:
    • Rossing, Peter;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Fonseca, Vivian;
    • Umpierrez, Guillermo E.;
    • Caramori, Maria Luiza;
    • Joseph, Amer;
    • Lambelet, Marc;
    • Lawatscheck, Robert;
    • Bakris, George L.
    Publication type:
    Article
    28
    29
    30
    31
    32

    The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386
    By:
    • Arnott, Clare;
    • Li, Jing‐Wei;
    • Cannon, Christopher P.;
    • Zeeuw, Dick;
    • Neuen, Brendon L.;
    • Heerspink, Hiddo J. L.;
    • Charytan, David M.;
    • Agarwal, Anubha;
    • Huffman, Mark D.;
    • Figtree, Gemma A.;
    • Bakris, George;
    • Chang, Tara I‐Hsin;
    • Feng, Kent;
    • Rosenthal, Norman;
    • Zinman, Bernard;
    • Jardine, Meg J.;
    • Perkovic, Vlado;
    • Neal, Bruce;
    • Mahaffey, Kenneth W.
    Publication type:
    Article
    33
    34

    Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 561, doi. 10.1111/dom.14252
    By:
    • Koomen, Jeroen V.;
    • Stevens, Jasper;
    • Bakris, George;
    • Correa‐Rotter, Ricardo;
    • Hou, Fan Fan;
    • Kitzman, Dalane W.;
    • Kohan, Donald;
    • Makino, Hirofumi;
    • McMurray, John J. V.;
    • Parving, Hans‐Henrik;
    • Perkovic, Vlado;
    • Tobe, Sheldon W.;
    • Zeeuw, Dick;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.

    Published in:
    Blood Pressure, 2012, v. 21, n. 2, p. 82, doi. 10.3109/08037051.2011.598699
    By:
    • Kjeldsen, Sverre E.;
    • Jamerson, Kenneth A.;
    • Bakris, George L.;
    • Pitt, Bertram;
    • Dahlöf, Björn;
    • Velazquez, Eric J.;
    • Hua, Tsushung A.;
    • Kelly, Roxzana Y.;
    • Zappe, Dion;
    • Hester, Allen;
    • Tuomilehto, Jaakko;
    • Östergren, Jan;
    • Ibsen, Hans;
    • Weber, Michael
    Publication type:
    Article
    41

    Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH Study.

    Published in:
    Blood Pressure, 2008, v. 17, n. 1, p. 7, doi. 10.1080/08037050801972857
    By:
    • Kjeldsen, Sverre E.;
    • Jamerson, Kenneth A.;
    • Bakris, George L.;
    • Pitt, Bertram;
    • Dahlöf, Björn;
    • Velazquez, Eric J.;
    • Gupte, Jitendra;
    • Staikos, Linda;
    • Hua, Tsushung A.;
    • Shi, Victor;
    • Hester, Allen;
    • Tuomilehto, Jaakko;
    • Östergren, Jan;
    • Ibsen, Hans;
    • Weber, Michael;
    • for the Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH) Investigators
    Publication type:
    Article
    42

    Exceptional early blood pressure control rates: The ACCOMPLISH trial.

    Published in:
    Blood Pressure, 2007, v. 16, n. 2, p. 80, doi. 10.1080/08037050701395571
    By:
    • Jamerson, Kenneth;
    • Bakris, George L.;
    • Dahlöf, Björn;
    • Pitt, Bertram;
    • Velazquez, Eric;
    • Gupte, Jitendra;
    • Lefkowitz, Martin;
    • Hester, Allen;
    • Shi, Victor;
    • Kjeldsen, Sverre E.;
    • Cushman, William;
    • Papademetriou, Vasilios;
    • Weber, Michael
    Publication type:
    Article
    43
    44

    Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular risk.

    Published in:
    Blood Pressure, 2007, v. 16, n. 1, p. 13, doi. 10.1080/08037050701217643
    By:
    • Weber, Michael A.;
    • Bakris, George L.;
    • Dahlöf, Björn;
    • Pitt, Bertram;
    • Velazquez, Eric;
    • Gupte, Jitendra;
    • Lefkowitz, Martin;
    • Hester, Allen;
    • Shi, Victor;
    • Weir, Matthew;
    • Kjeldsen, Sverre;
    • Massie, Barry;
    • Nesbitt, Shawna;
    • Ofili, Elizabeth;
    • Jamerson, Kenneth;
    • for the Accomplish Investigators
    Publication type:
    Article
    45
    46
    47
    48
    49
    50